These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7734773)

  • 1. [Characterization of the mechanism of cross-resistance to vinca alkaloids and taxoids in the human J82 bladder tumor cell line].
    Debal V; Allam N; Morjani H; Millot JM; Gourdier B; Breillout F; Manfait M
    Bull Cancer; 1994 Oct; 81(10):891-3. PubMed ID: 7734773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of a navelbine-resistant bladder carcinoma cell line cross-resistant to taxoids.
    Debal V; Allam N; Morjani H; Millot JM; Braguer D; Breillout F; Manfait M
    Br J Cancer; 1994 Dec; 70(6):1118-25. PubMed ID: 7981063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant decrease of resistance and modifications of the cytoskeleton after all-trans retinoic acid and phorbol ester treatments in a navelbine-resistant bladder carcinoma cell line.
    Debal V; Breillout F; Manfait M
    Anticancer Res; 1997; 17(2A):1147-54. PubMed ID: 9137463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital morphonuclear analyses of sensitive versus resistant neoplastic cells to vinca-alkaloid, alkylating, and intercalating drugs.
    Pauwels O; Kiss R
    Cytometry; 1991; 12(5):388-97. PubMed ID: 1935454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
    Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT
    Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine).
    Adams DJ; Knick VC
    Invest New Drugs; 1995; 13(1):13-21. PubMed ID: 7499103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
    Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
    PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E; Tarasiuk J; Garnier-Suillerot A
    Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules.
    Binet S; Chaineau E; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V
    Int J Cancer; 1990 Aug; 46(2):262-6. PubMed ID: 2200754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrotubule agents].
    Niitani H; Hisakatsu S
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):34-41. PubMed ID: 8093658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical mechanism of cross-resistance to paclitaxel in a mitomycin c-resistant human bladder cancer cell line.
    Bleicher RJ; Xia H; Zaren HA; Singh SV
    Cancer Lett; 2000 Mar; 150(2):129-35. PubMed ID: 10704734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4.
    Zhang CC; Yang JM; Bash-Babula J; White E; Murphy M; Levine AJ; Hait WN
    Cancer Res; 1999 Aug; 59(15):3663-70. PubMed ID: 10446979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of microtubule inhibitors on etoposide accumulation and DNA damage in human K562 cells in vitro.
    Yalowich JC
    Cancer Res; 1987 Feb; 47(4):1010-5. PubMed ID: 2879622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
    Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence.
    Binet S; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):5-8. PubMed ID: 2652320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A; Soprano DR; Parekh HK
    Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line.
    Zhou J; Cheng SC; Luo D; Xie Y
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1237-42. PubMed ID: 11162660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
    Smith CD; Zhang X; Mooberry SL; Patterson GM; Moore RE
    Cancer Res; 1994 Jul; 54(14):3779-84. PubMed ID: 7913408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital cell image analysis of verapamil-induced effects in chemosensitive and chemoresistant neoplastic cell lines.
    Etiévant C; Pauwels O; Kiss R
    J Cancer Res Clin Oncol; 1993; 120(1-2):76-84. PubMed ID: 8270613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.